Identifying Preanalytic and Postanalytic Laboratory Quality Gaps Using a Data Warehouse and Structured Multidisciplinary Process.

Context.--The laboratory total testing process includes preanalytic, analytic, and postanalytic phases, but most laboratory quality improvement efforts address the analytic phase. Expanding quality improvement to preanalytic and postanalytic phases via use of medical data warehouses, repositories th...

Full description

Bibliographic Details
Published in:Archives of Pathology & Laboratory Medicine Vol. 143; no. 4; pp. 518 - 525
Main Authors: Raebel, Marsha A., Quintana, LeeAnn M., Schroeder, Emily B., Epner, Paul L., Shetterly, Susan M., Pieper, Lisa E., Bechtel, Laura K., Smith, David H., Sterrett, Andrew T., Chorny, Joseph A., Lubin, Ira M.
Format: research tables/charts Journal Article
Published: College of American Pathologists Apr2019
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135659593&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 135659593
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00039985
        1FS
      jtl: Archives of Pathology & Laboratory Medicine
      issn: 00039985
      maglogo: N
    pubinfo:
      dt: Apr2019
      vid: 143
      iid: 4
      pid: 2550
      pub: College of American Pathologists
      place: Northfield, Illinois
    artinfo:
      ui:
        135659593
        135659593
        135659593
        10.5858/arpa.2018-0093-OA
        135659593
      ppf: 518
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Identifying Preanalytic and Postanalytic Laboratory Quality Gaps Using a Data Warehouse and Structured Multidisciplinary Process.
      aug:
        au:
          Raebel, Marsha A.
          Quintana, LeeAnn M.
          Schroeder, Emily B.
          Epner, Paul L.
          Shetterly, Susan M.
          Pieper, Lisa E.
          Bechtel, Laura K.
          Smith, David H.
          Sterrett, Andrew T.
          Chorny, Joseph A.
          Lubin, Ira M.
        affil: Institute for Health Research
      sug:
        subj:
          Clinical Laboratories
          Quality Improvement
          Multidisciplinary Care Team
          Data Warehouse Utilization
          Human
          Leaders
          Practice Guidelines
          Documentation
          Drug Monitoring
          Alanine Aminotransferase Blood
          Aspartate Aminotransferase Blood
          Blood Cell Count
          Creatinine Blood
          Antirheumatic Agents Therapeutic Use
      ab: Context.--The laboratory total testing process includes preanalytic, analytic, and postanalytic phases, but most laboratory quality improvement efforts address the analytic phase. Expanding quality improvement to preanalytic and postanalytic phases via use of medical data warehouses, repositories that include clinical, utilization, and administrative data, can improve patient care by ensuring appropriate test utilization. Cross-department, multidisciplinary collaboration to address gaps and improve patient and system outcomes is beneficial. Objective.--To demonstrate medical data warehouse utility for characterizing laboratory-associated quality gaps amenable to preanalytic or postanalytic interventions. Design.--A multidisciplinary team identified quality gaps. Medical data warehouse data were queried to characterize gaps. Organizational leaders were interviewed about quality improvement priorities. A decision aid with elements including national guidelines, local and national importance, and measurable outcomes was completed for each gap. Results.--Gaps identified included (1) test ordering; (2) diagnosis, detection, and documentation, and (3) high-risk medication monitoring. After examination of medical data warehouse data including enrollment, diagnoses, laboratory, pharmacy, and procedures for baseline performance, high-risk medication monitoring was selected, specifically alanine aminotransferase, aspartate aminotransferase, complete blood count, and creatinine testing among patients receiving disease-modifying antirheumatic drugs. The test utilization gap was in monitoring timeliness (eg, .60% of patients had a monitoring gap exceeding the guideline recommended frequency). Other contributors to selecting this gap were organizational enthusiasm, regulatory labeling, and feasibility of a significant laboratory role in addressing the gap. Conclusions.--A multidisciplinary process facilitated identification and selection of a laboratory medicine quality gap. Medical data warehouse data were instrumental in characterizing gaps.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N